The PI3K/Akt/mTOR signaling pathway, which plays a significant role in tumor progression, has also been implicated in promoting glycolysis in HCC cells by regulating GLUT4 and HK2 (28, 29). This evidence concerns the gene HK2 and hepatocellular carcinoma.